Dr. Reddy's Laboratories Limited announced that Ms. Penny Wan (DIN: 09479493) has been appointed as an Additional Director, categorized as Independent, on the Board of Dr. Reddy's Laboratories Ltd., for a term of five consecutive years, effective January 28, 2022. Her appointment was approved by the Board based on recommendations of the Nomination, Governance and Compensation Committee and is subject to approval of shareholders. Penny Wan was most recently Amgen's Vice President of the Japan and Asia Pacific region.

With over 20 years of experience in the biopharmaceuticals industry, she led Amgen's geographic expansion efforts in the region. Since joining the Company in 2014, she has been instrumental in building Amgen's commercial presence across the region, ensuring that innovative medicines reach patients, payers and physicians in these markets.